Preliminary pilot studies investigating semaglutide in people with AUD have reported early signals, with some participants experiencing reduced alcohol cravings and fewer heavy drinking days
They want to see complaints, negative reviews, or concerns about side effects, refunds, or legitimacy
Rest is a physiological state, not just a lack of movement
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
Your metabolism adapts, making continued weight loss slower than it was during the initial months
Whilst some degree of trial and adjustment is normal, certain situations warrant prompt discussion with your healthcare provider